Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase (Q46593571)

23 December 2017

title

Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase (English)

1 reference

23 December 2017

0 references

Akinori Yoda

1

1 reference

23 December 2017

Kyoko Toyoshima

2

1 reference

23 December 2017

Yasuhide Watanabe

3

1 reference

23 December 2017

Nobuyuki Onishi

4

1 reference

23 December 2017

Yuki Hazaka

5

1 reference

23 December 2017

Yusuke Tsukuda

6

1 reference

23 December 2017

Junichi Tsukada

7

1 reference

23 December 2017

Takeshi Kondo

8

1 reference

23 December 2017

Yoshiya Tanaka

9

1 reference

23 December 2017

Yasuhiro Minami

10

1 reference

23 December 2017

language of work or name

English

0 references

publication date

15 May 2008

1 reference

23 December 2017

Journal of Biological Chemistry

published in

1 reference

23 December 2017

volume

283

1 reference

23 December 2017

page(s)

18969-18979

1 reference

23 December 2017

issue

27

1 reference

23 December 2017

Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

The role of PML in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Molecular targets of arsenic trioxide in malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Arsenic trioxide, a therapeutic agent for APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Arsenical-based cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

In vitro effect of arsenical compounds on glutathione-related enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

The potential biological mechanisms of arsenic-induced diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

DNA damage tumor suppressor genes and genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Genomic instability and cancer: networks involved in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

21 January 2018

The Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Chk1 in the DNA damage response: conserved roles from yeasts to mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

The DNA damage response: sensing and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Map kinase signaling pathways and hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

The structure and regulation of protein phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Wip1-deficient mice are resistant to common cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

A novel Drosophila nuclear protein serine/threonine kinase expressed in the germline during its establishment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Kinetic analysis of human serine/threonine protein phosphatase 2Calpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800560200

21 January 2018

Identifiers

DOI

10.1074/JBC.M800560200

1 reference

23 December 2017

PubMed ID

18482988

1 reference

23 December 2017